Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient \>= 18 years and \<= 50 years
Patient diagnosed with AS or PsA
Patient to be initiated on adalimumab (according to the Marketing Authorization and Belgian reimbursement criteria)
Patient willing to sign informed consent
You may not be if
Any contraindication for adalimumab as specified in the corresponding Summary of Product Characteristics (SmPC)
Patient previously treated with biologics
Patient participating in other AbbVie-sponsored trials
Clareo Health | Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
